The Pharma Data

OCTOBER 23, 2020

of the University of Illinois at Chicago/Metropolitan Group Hospitals, and colleagues found that women in the United States with limited English-language proficiency (LEP), especially Spanish speakers, appear to be at risk for lower rates of screening mammogram, regardless of their socioeconomic and breast cancer risk factors.

Hospitals 52

Hospitals Clinical Trials Trials Treatment 52

The Pharma Data

NOVEMBER 22, 2021

Located within the Cambridge Biomedical Campus1, the physical propinquity of the structure’s m2 laboratories to leading hospitals, the University of Cambridge, other exploration institutions and a number of biotech companies will promote a culture of open cooperation and invention in its inviting open spaces.

Molecular Biology 52

Molecular Biology Laboratories Engineering Hospitals 52

The Pharma Data

SEPTEMBER 5, 2021

“This new analysis from NAVIGATOR is exciting for the up to one in five severe asthma patients who have comorbid nasal polyps,” said Professor Andrew Menzies-Gow, director of the Lung Division, Royal Brompton Hospital, London, UK, the principal investigator of the NAVIGATOR trial.

Trials 52

Trials Clinical Trials Therapies Treatment 52

The Pharma Data

NOVEMBER 10, 2020

The trial is a dose-ranging, open-label study that will enroll 60 patients in the U.S. Additionally, oral capsules provide the convenience of home use, and increase patient compliance by eliminating the need for infusions in a clinic or hospital setting. Grand View Research August 2018 ( [link] ). NEW YORK and LONDON, Nov.

Clinical Trials 40

Clinical Trials Science Disease Trials 40

The Pharma Data

DECEMBER 13, 2020

Professor Jie Wang from Cancer Hospital Chinese Academy of Medical Sciences is the leading principal investigator for the study. On December17 ,2018, Toripalimab obtained conditional approval from the NMPA, for the 2 nd line treatment of patients with unresectable or metastatic melanoma.

Treatment 40

Treatment Clinical Trials Biosimilars Pharmaceutical Companies 40

Drug Hunter

AUGUST 21, 2023

Overall, only a few prodrugs for CNS disorders have even reached clinical trials , so for the most part traditional property-based drug design remains the best bet for the vast majority of programs. What is K p,uu ? The disease leads to severe disruptions of sleeping, uncontrollable aggression, and psychosis and is fatal if untreated.

Drugs 206

Drugs Disease Targeted Protein Degradation Screening Hits 206

The Pharma Data

JUNE 28, 2021

2,8 In Japan, more than 70% of patients with migraine have never visited a hospital to treat their disease, and about 50% of patients try to treat their disease on their own with over-the-counter medications. ” Aimovig (erenumab-aooe) was approved as a preventive treatment for migraine in adults in the United States on May 17, 2018.

Treatment 52

Treatment Disease Clinical Trials Hospitals 52

The Pharma Data

JANUARY 21, 2021

Prior to joining Labcorp, she held multiple appointments with The Children’s Hospital of Philadelphia, including Patient Safety Officer, chief of the Division of Transfusion Medicine and Vice-Chief of Pathology and Laboratory Medicine. since May 2018. She succeeds Dot Adcock, who retired. Dauer succeeds Stephan Ludwig as chairman.

Laboratories 52

Laboratories Pharmaceuticals Clinical Development Engineering 52

The Pharma Data

DECEMBER 17, 2020

In this study, data from the RADARS ® System’s Survey of Non-Medical Use of Prescription Drugs (NMURx) Program online cross-sectional general population national surveys are analyzed from 2018 from four countries, Germany, Italy, Spain, and the UK, with 45,000 total responses.

Government 52

Government Production Pharmaceuticals Pharmaceutical Companies 52

The Pharma Data

MAY 31, 2022

Jude Children’s Research Hospital. More than 5,000 patients have now been treated worldwide with Evrysdi in clinical trials, compassionate use or real-world settings. Evrysdi was granted PRIME designation by the European Medicines Agency (EMA) in 2018 and Orphan Drug Designation by the U.S

FDA Approval 52

FDA Approval FDA Treatment Clinical Trials 52

Agency IQ

AUGUST 23, 2024

The office, which is responsible for directly reviewing and regulating medical devices and diagnostics, was established under a major restructuring of CDRH in 2018-2019 as part of CDRH’s “Total Product Lifecycle (TPLC)” approach. Stenzel had joined the agency as Office Director in 2018 and helmed the OHT7 through the pandemic.

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

JUNE 29, 2023

The notice specifically made mention of a 2018 draft guidance document, Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements, and noted that “it is not fully understood how consumers will interpret specific quantitative claims.” Section III.C.)

FDA 40

FDA Drugs Regulations Production 40

Agency IQ

JUNE 7, 2024

After the passage of the 2018 Farm Bill, certain strains of Cannabis sativa – those containing less than 0.3% And indeed, a review of one poison control center’s experience showed multiple cases of tianeptine intoxication requiring hospitalization, as well as multiple cases of severe tianeptine withdrawal.

FDA 40

FDA Science Production Marketing 40

Broad Institute

MAY 2, 2024

In 2018, she graduated with a bachelor’s degree in computer science and biology and joined the lab of Gad Getz at the Broad Institute of MIT and Harvard to complete her master’s. In 2021, Martin competed in the US Olympic trials in a lightweight double, and won the world-renowned Head of the Charles regatta in lightweight single sculls.

Science 124

Science Medical Schools Hospitals Disease 124

The Pharma Data

JULY 8, 2021

8) There were no clinically meaningful differences in safety results between the tezepelumab and placebo groups in the NAVIGATOR trial.(8) 8) There were no clinically meaningful differences in safety results between the tezepelumab and placebo groups in the NAVIGATOR trial.(8) About Severe Asthma. Globally, there are approximately 2.5

FDA 52

FDA Trials Therapies Treatment 52

The Pharma Data

MARCH 3, 2022

Pfizer will publish outcomes from this clinical trial at a future date. 1 This decision follows the FDA’s November 2018 decision to grant Fast Track status to RSVpreF. million outpatient visits and 58,000 hospitalizations occur each year among children younger than five years old. 8,9 For older adults in the U.S.,

Virus 52

Virus Vaccine Clinical Trials Trials 52

The Pharma Data

MARCH 16, 2022

The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessment EMPA-KIDNEY is the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease to date Detailed results are expected to be presented later this year.

Trials 52

Trials Disease Hospitals Clinical Trials 52

The Pharma Data

MARCH 29, 2022

The approval by the Japanese Ministry of Health, Labour and Welfare was based on positive results from the ANNEXA-4 Phase III clinical trial showing Ondexxya rapidly and markedly reversed anti-FXa activity in patients with acute major bleeding. During the trial, 10.4% of patients died during the trial.

Trials 52

Trials Hospitals Science Clinical Trials 52

The Pharma Data

OCTOBER 30, 2020

Previously approved under an Emergency Use Authorization (EUA), Veklury is now fully cleared for the treatment of hospitalized patients with COVID-19. hospitals. A revised EUA for the unapproved use of Veklury is in effect for hospitalized pediatric patients less than 12 years of age weighing at least 3.5

FDA Approval 52

FDA Approval Hospitals Treatment FDA 52

The Pharma Data

JANUARY 25, 2021

And a 2018 clinical trial fueled concerns about risks: It found that people age 70 and up who were randomly assigned to take low-dose aspirin were actually more likely to die of colon cancer than nonusers. ” The trial findings raised many questions, including: Is starting aspirin after age 70 the problem? © 2021 HealthDay.

Doctors 52

Doctors Hospitals Government Clinical Trials 52

The Pharma Data

APRIL 17, 2021

First introduced in 2013, TECFIDERA has demonstrated a well-established safety and efficacy profile with more than 10 years of data from clinical trials and real-world experience. Results from clinical trials and more than a decade of real-world evidence have demonstrated the efficacy, safety and tolerability of dimethyl fumarate.

Treatment 52

Treatment Clinical Trials Disease Trials 52

The Pharma Data

OCTOBER 20, 2020

News’ Best Hospitals for Cancer list. In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. In fact, they’ve been ranked No.

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

The Pharma Data

JUNE 26, 2021

Part of the industry leading EXPLORER clinical research program, EINSTEIN-Jr is the largest study completed to date evaluating the treatment of pediatric patients with VTE, and UNIVERSE is the first clinical trial to examine a DOAC for the prevention of thromboembolism in congenital heart disease post-Fontan pediatric patients.

Doctors 52

Doctors Hospitals Treatment Clinical Trials 52

The Pharma Data

AUGUST 8, 2020

With its latest trial win, Eli Lilly and its Chinese partner Innovent Biologics are eyeing an all-important front-line non-small cell lung cancer approval in China for their PD-1 checkpoint inhibitor, Tyvyt. In November, Keytruda nabbed its chemo combo squamous go-ahead in China based on data from the phase 3 Keynote-407 trial.

Trials 52

Trials Pharmacy Hospitals International 52

Agency IQ

APRIL 19, 2024

Committee discussions noted the potential for earlier readout and faster completion of studies, with an expectation that the FDA will ultimately require follow-through with confirmatory trials. The analysis included 20 trials for 12,926 patients with IPD.

FDA 40

FDA Disease Trials Clinical Trials 40

The Pharma Data

NOVEMBER 8, 2020

from the Hematology Department of Peking University People’s Hospital, are the principal investigators of these studies. Following the data releases in 2018 and 2019, this will be the third time that Ascentage Pharma has presented updated clinical data of HQP1351 at the ASH Annual Meeting. Qian Jiang , M.D.,

Trials 40

Trials Drugs FDA Therapies 40

The Pharma Data

JANUARY 13, 2021

With the recent announcement that the RATIONALE 303 trial met its primary endpoint of overall survival at its interim analysis, three Phase 3 trials of tislelizumab in NSCLC have achieved a positive outcome at interim analysis,” commented Yong (Ben) Ben, M.D., Chief Medical Officer, Immuno-Oncology at BeiGene.

Production 52

Production Trials Clinical Trials Treatment 52

The Pharma Data

JUNE 18, 2021

The FDA’s decision is based on evidence from Pfizer’s clinical program in adults, including Phase 1 and 2 trials, and three Phase 3 trials (NCT03760146, NCT03828617, and NCT03835975) describing the safety and evaluating the immunogenicity of the vaccine. On September 20, 2018, Pfizer announced the U.S. October 24th, 2018.

Vaccine 52

Vaccine FDA Approval FDA Disease 52

The Pharma Data

OCTOBER 28, 2020

We are pursuing an accelerated approval pathway for remestemcel-L in the treatment of children with SR-aGVHD, and a parallel approval pathway for COVID-19 ARDS if the randomized controlled Phase 3 trial is positive.”. The dosing regimen in the Phase 3 is the same as in the pilot trial.

Treatment 40

Treatment Trials Disease Production 40

The Pharma Data

NOVEMBER 19, 2020

The study data came from a prospective study of participants at Rutgers and affiliated hospitals during the early phase of the pandemic. The study evaluated 546 healthcare works with direct patient exposure at two hospitals in New Jersey and 283 non-healthcare workers that did not have direct patient contact.

Research 52

Research Nurses Disease Immune Response 52

Agency IQ

OCTOBER 6, 2023

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), “between 2008 and 2015, amphetamine-related hospitalizations more than tripled, increasing from 55,447 instances to 206,180. While stimulant use disorder is increasing, there are currently no FDA-approved medications.

FDA 40

FDA Treatment Production Trials 40

Agency IQ

JANUARY 26, 2024

Such a situation is commonplace in the clinical trial realm, in which investigational drug products which are not already FDA approved are administered to patients. In many hospitals and other institutions, medications are taken out of their original “bulk” container and placed into unit-dose packaging , often referred to as blister packs.

Science 40

Science FDA Production Packaging 40

The Pharma Data

OCTOBER 25, 2020

In a sample of charts from 56 patients with SCD, voxelotor increased hemoglobin by more than 1 g/dL on average and decreased hemolysis markers to a degree consistent with the randomized controlled HOPE trial results. 2010;376(9757):2018-2031. . Details of the ASCAT presentations are as follows: Wednesday , Oct.

Treatment 40

Treatment Disease FDA FDA Approval 40

The Pharma Data

NOVEMBER 4, 2020

Reaffirmed c linical trial results from study of VASCEPA in China are expected by year end 2020 : Assuming positive results from this study conducted by Amarin’s commercial partner for VASCEPA in China, regulatory submission in China could follow promptly thereafter. commercial team. “In

Production 40

Production Trials Disease FDA 40

The Pharma Data

JUNE 18, 2021

lead study investigator of the Phase 3 RESONATE-2 trial, and Professor of Medicine at the Wilmot Cancer Institute, University of Rochester. IMBRUVICA ® is the most comprehensively studied BTK inhibitor, with more than 150 ongoing clinical trials. call your healthcare provider or go to the nearest hospital emergency room right away. .

FDA Approval 40

FDA Approval Treatment Therapies FDA 40

The Pharma Data

APRIL 23, 2021

The ongoing phase 1 GARNET trial is evaluating dostarlimab as monotherapy in patients with advanced solid tumours. Published 2018. About GARNET. Such factors include, but are not limited to, those described in the Company’s Annual Report on Form 20-F for 2020 and any impacts of the COVID-19 pandemic. [i] Accessed January 2021.

Therapies 40

Therapies Treatment Licensing Licensing 40

Codon

JULY 14, 2024

However, the subsequent death of another patient thrust Denys into a contentious trial. Despite the high costs, researchers in Kyoto generated enough cultured platelets in 2022 to transfuse a 55-year-old woman for an initial human trial. The results of the trial are expected at the end of 2024. Data from Rousseau G.F.

Production 143

Production Clinical Trials Trials Therapies 143